Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. > Summary
Court Case Number 1:17-cv-00389
Filing Date Apr 7, 2017
Termination Date Jan 2, 2019
Court Delaware District Court
Status Dismissed - Settled
JudgesRichard G. Andrews
Plaintiff
Defendant
Plaintiff Attorneys
10Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Christopher E. Loh
Venable
Novartis
Attorney Name: Christina A. Schwarz
Venable
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Jared L. Stringham
Venable
Novartis
Attorney Name: Shannon K. Clark
Venable
Novartis
Attorney Name: Laura K Fishwick
Venable
Novartis
Attorney Name: Susanne L. Flanders
Venable
Novartis
Attorney Name: Benjamin A. Smyth
McCarter & English
Novartis
Attorney Name: Charlotte C. Jacobsen
Venable
Defendant Attorneys
8Viatris Inc.
Attorney Name: Bryan D. Beel
Perkins Coie
Viatris Inc.
Attorney Name: Shannon Bloodworth
Perkins Coie
Viatris Inc.
Attorney Name: James M. Lennon
Devlin Law Firm
Viatris Inc.
Attorney Name: Robert M. Vrana
Young Conaway Stargatt & Taylor
Viatris Inc.
Attorney Name: Brandon M. White
Perkins Coie
Viatris Inc.
Attorney Name: David L. Anstaett
Perkins Coie
Viatris Inc.
Attorney Name: Danielle S. Grant-Keane
Perkins Coie
Viatris Inc.
Attorney Name: Maria Alice Stubbings
Perkins Coie
Counter Defendant
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Counter Claimant
Viatris Inc.
Attorney Name: James M. Lennon
Devlin Law Firm
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08778962 | Treatment of solid tumors with rapamycin derivatives | Jul 15, 2014 |
| 08617598 | Pharmaceutical compositions comprising colloidal silicon dioxide | Dec 31, 2013 |
| 05665772 | O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants | Sep 9, 1997 |
